Dutch guidelines for the diagnosis and treatment of chronic lymphocytic leukaemia

AUTHOR GROUP

Dutch guidelines for the diagnosis and treatment of chronic lymphocytic leukaemia

AUTHOR GROUP

Research output: Contribution to journal › Review article › Academic › peer-review

Abstract

In recent years, considerable progress has been made in the treatment of patients with chronic lymphocytic leukaemia (CLL). Therefore, the CLL working group of the Dutch/Belgium Haemato-Oncology Foundation for Adults in the Netherlands (HOVON) framework revised the Dutch guidelines based on new studies and expert opinion of members of the working group

Original language	English
Pages (from-to)	68-74
Journal	Netherlands journal of medicine
Volume	74
Issue number	2
Publication status	Published - Feb 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Chronic lymphocytic leukaemia
CLL
guidelines
HOVON

Cite this

@article{5612bec9bcf34b7f8249bd5b4dc38316,

title = "Dutch guidelines for the diagnosis and treatment of chronic lymphocytic leukaemia",

abstract = "In recent years, considerable progress has been made in the treatment of patients with chronic lymphocytic leukaemia (CLL). Therefore, the CLL working group of the Dutch/Belgium Haemato-Oncology Foundation for Adults in the Netherlands (HOVON) framework revised the Dutch guidelines based on new studies and expert opinion of members of the working group",

keywords = "Chronic lymphocytic leukaemia, CLL, guidelines, HOVON",

author = "\{AUTHOR GROUP\} and S. Kersting and M.-D. Levin and M. Chamuleau and Daenen, \{S. M. G. J.\} and Dompeling, \{E. C.\} and Doorduijn, \{J. K.\} and \{van Gelder\}, M. and M. Hoogendoorn and Kerst, \{J. M.\} and M. Nijland and Nijziel, \{M. R.\} and Posthuma, \{E. F. M.\} and Raymakers, \{R. A. P.\} and Schaafsma, \{M. R.\} and Silbermann, \{M. H.\} and \{van der Straaten\}, \{H. M.\} and Veelken, \{J. H.\} and Vos, \{J. M. I.\} and S. Wittebol and \{van Oers\}, \{M. H. J.\} and Kater, \{A. P.\}",

year = "2016",

month = feb,

language = "English",

volume = "74",

pages = "68--74",

journal = "Netherlands journal of medicine",

issn = "0300-2977",

publisher = "Van Zuiden Communications BV",

number = "2",

}

TY - JOUR

T1 - Dutch guidelines for the diagnosis and treatment of chronic lymphocytic leukaemia

AU - AUTHOR GROUP

AU - Kersting, S.

AU - Levin, M.-D.

AU - Chamuleau, M.

AU - Daenen, S. M. G. J.

AU - Dompeling, E. C.

AU - Doorduijn, J. K.

AU - van Gelder, M.

AU - Hoogendoorn, M.

AU - Kerst, J. M.

AU - Nijland, M.

AU - Nijziel, M. R.

AU - Posthuma, E. F. M.

AU - Raymakers, R. A. P.

AU - Schaafsma, M. R.

AU - Silbermann, M. H.

AU - van der Straaten, H. M.

AU - Veelken, J. H.

AU - Vos, J. M. I.

AU - Wittebol, S.

AU - van Oers, M. H. J.

AU - Kater, A. P.

PY - 2016/2

Y1 - 2016/2

N2 - In recent years, considerable progress has been made in the treatment of patients with chronic lymphocytic leukaemia (CLL). Therefore, the CLL working group of the Dutch/Belgium Haemato-Oncology Foundation for Adults in the Netherlands (HOVON) framework revised the Dutch guidelines based on new studies and expert opinion of members of the working group

AB - In recent years, considerable progress has been made in the treatment of patients with chronic lymphocytic leukaemia (CLL). Therefore, the CLL working group of the Dutch/Belgium Haemato-Oncology Foundation for Adults in the Netherlands (HOVON) framework revised the Dutch guidelines based on new studies and expert opinion of members of the working group

KW - Chronic lymphocytic leukaemia

KW - CLL

KW - guidelines

KW - HOVON

M3 - Review article

C2 - 26951351

SN - 0300-2977

VL - 74

SP - 68

EP - 74

JO - Netherlands journal of medicine

JF - Netherlands journal of medicine

IS - 2

ER -

Dutch guidelines for the diagnosis and treatment of chronic lymphocytic leukaemia

Abstract

UN SDGs

Keywords

Fingerprint

Cite this